Total Nutraceutical (ERGO) 0.0700 $ERGO UPDATE -- Entia

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Total Nutraceutical (ERGO) 0.0700 $ERGO

UPDATE -- Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2(R) Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.
GlobeNewswire - Mon Dec 21, 2:12PM CST
Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported greater-than-expected initial enrollment in Entia's Chronic Kidney Disease study. This milestone was achieved during his recent kickoff visit to the study's test sites in Columbia (South America) and on the Caribbean island of Bonaire. The initial enrollees represent more than 25% of the quantity of study participants ultimately anticipated to enroll.

Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2(R) Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.
GlobeNewswire - Mon Dec 21, 7:50AM CST
Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported greater-than-expected initial enrollment in Entia's Chronic Kidney Disease study. This milestone was achieved during his recent kickoff visit to the study's test sites in Columbia (South America) and on the Caribbean island of Bonaire. The initial enrollees represent more than 25% of the quantity of study participants ultimately anticipated to enroll.

Ergomed Increases Its Co-Development Contribution up to $12,000,000 in CEL-SCI's Phase 3 Head and Neck Cancer Trial
BusinessWire - Mon Oct 05, 7:00AM CDT
CEL-SCI Corporation (NYSE MKT: CVM) ("CEL SCI" or the "Company" and its Clinical Research Organization (CRO) Ergomed plc (AIM:ERGO) today announced that they have expanded their co-development agreement with increased activities to be undertaken by Ergomed. Pursuant to the expanded co-development agreement, Ergomed's contribution to the Phase 3 study will increase from $10,000,000 to $12,000,000. The companies are undertaking the Phase 3 trial of CEL-SCI's investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in patients with advanced primary head and neck cancer.
CVM: 0.50 (unch)

Entia Biosciences, Inc. Names Chief Executive Officer to Manage Growth of Consumer Health Products and To Launch New Medical Food Brands
ACCESSWIRE - Thu Aug 13, 8:55AM CDT
New Business Strategy to Capitalize on Unique, Innovative and Proprietary Entia Products

Entia Biosciences CEO Dr. Hausman to Represent GROH(R) at Cosmoprof North America
ACCESSWIRE - Thu Jul 09, 1:13PM CDT
PORTLAND, OR / ACCESSWIRE / July 9, 2015 / Entia Biosciences, Inc. (OTCQB: ERGO), is excited to announce Dr. Marvin S. Hausman, MD and CEO will be representing the Company's GROH(R) Professional brand of hair and skin care products at Cosmoprof North America (CPNA), the largest international B2B beauty event in the Americas.

Entia Biosciences CEO Dr. Hausman to Represent GROH at Cosmoprof North America
eTeligis - Thu Jul 09, 12:57PM CDT
PORTLAND, OR, United States, via ETELIGIS INC., 07/09/2015 - - Entia Biosciences (OTCQB: ERGO), is excited to announce Dr. Marvin S. Hausman, MD and CEO will be representing the Company's GROH(R) Professional brand of hair and skin care products at Cosmoprof North America (CPNA), the largest international B2B beauty event in the Americas.

Entia Biosciences CEO and SAB Member Invited to Chair Sessions and Speak at 17th International Functional Food Conference
ACCESSWIRE - Fri Nov 14, 9:15AM CST
SHERWOOD, OR / ACCESSWIRE / November 14, 2014 / Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, announces that Marvin S. Hausman MD, CEO, will speak on the subject - "Treatment of Anemia with a Natural Mushroom-Based Medical Food ErgoD2." The 17th International Conference of FFC, Discovery, Utilization, and Control of Bioactive Components and Functional Foods, November 18-19, 2014, will be held at the University of San Diego, San Diego, California, USA.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 8

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 6

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 3

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 7

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 10

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 4

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 7

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 6

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 5

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 10

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading

Top 5 Most Recently Viewed Articles

Esperion Partners with Dr. Reddy's to Protect NEXLETOL® and NEXLIZET®

Updated Category News Views 185

Esperion's Strategic Settlement with Dr. Reddy’s Laboratories Esperion (NASDAQ: ESPR) has recently solidified its position in the competitive biopharmaceutical market with a pivotal agreement with Dr. Reddy’s Laboratories, Inc. This partnership marks a crucial step in the ongoing efforts to protect the company’s flagship products, NEXLETOL® (bempedoic acid) and...

Continue Reading
Marshall Group's Continued Success in the Audio Industry

Updated Category News Views 113

Marshall Group Reports Impressive Growth Marshall Group has continued its impressive growth into the second quarter of 2024, achieving a notable 15% increase in net sales, totaling SEK 1,097.5 million. Additionally, the adjusted operating profit rose significantly to SEK 242.1 million, resulting in an impressive adjusted operating margin of 22.1%. Building on a Strong...

Continue Reading
Godawan Artisanal Indian Single Malt Arrives in the UK

Updated Category News Views 439

Godawan Artisanal Indian Single Malt Makes Its UK Debut Recently, an exciting milestone was reached with the launch of Godawan Artisanal Indian Single Malt in the UK. This premium whisky, crafted by Diageo India, has captured hearts and palates worldwide. With two distinctive expressions, Rich & Rounded and Fruit & Spice, Godawan is all set to tantalize whisky enthusiasts...

Continue Reading
China's Strategic Response to US Tariff Increases Affects Companies

Updated Category News Views 327

China's Response to Increased US Tariffs China has taken a strong stand against recent tariff increases implemented by the U.S., positioning itself as a formidable player in international trade. This reaction includes reciprocal tariffs on a range of American products, sanctions on U.S. companies, and plans to address these issues through the World Trade Organization....

Continue Reading
Infosys and AGCO Join Forces for Transformational Success

Updated Category News Views 190

Infosys and AGCO Team Up for IT and HR Transformation Building on a longstanding relationship to enhance AGCO's operational framework for growth by leveraging Infosys Cobalt and Infosys Topaz. Infosys (NSE: INFY), a global leader in next-generation digital services and consulting, has announced the continuation of its strategic partnership with AGCO Corporation (NYSE:...

Continue Reading